# An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs

> **NCT07142655** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1500 (actual)

## Conditions studied

- Peripheral Arterial Disease (PAD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07142655
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-12
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07142655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07142655, "An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07142655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*